A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Published:2002-09-10 Issue:12 Volume:24 Page:1054-1059
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Espinosa Enrique,Zamora Pilar,Millá Alfredo,Morales Serafin,Molina Raquel,Mira M.,González Barón Manuel

Publisher

Wiley

Subject

Otorhinolaryngology

Reference31 articles.

1. Standard chemotherapy for squamous cell head and neck cancer. What we have learned from randomized trials;Browman;Semin Oncol,1994

2. Randomized phase II trial of weekly methotrexate versus two schedules of triweekly paclitaxel in patients with metastatic or recurrent squamous cell carcinoma of the head and neck;Vermorken;Proc Am Soc Clin Oncol,1999

3. A phase III randomized trial comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck;Jacobs;J Clin Oncol,1992

4. Randomized comparison of cisplatin and 5-fluorouracil versus carboplatin + 5FU versus methotrexate in advanced squamous cell carcinoma of the head and neck;Forastiere;J Clin Oncol,1992

5. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin in recurrent or metastatic squamous cell carcinoma of the head and neck;Clavel;Ann Oncol,1994

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients;Anti-Cancer Drugs;2016-04

2. Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates;F1000Research;2015-07-13

3. Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck;Expert Review of Anticancer Therapy;2011-03

4. Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy;Clinical Immunology;2011-03

5. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence;Acta Oto-Laryngologica;2009-01